Unlock instant, AI-driven research and patent intelligence for your innovation.

Cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition and application thereof

A technology of anti-lung cancer drugs and compositions, which is applied in the direction of drug combinations, anti-tumor drugs, and active ingredients of heterocyclic compounds, etc., can solve the problems of easy metastasis of lung cancer, missed treatment period, and reduced anti-cancer effect, achieving low toxicity, Reduce the dosage and enhance the inhibitory effect

Pending Publication Date: 2022-01-21
DALIAN UNIV OF TECH PANJIN INST OF IND TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

One of the reasons for the extremely high mortality rate of lung cancer is that most patients are already in the advanced stage when they are diagnosed with lung cancer, and have missed the best treatment period, and lung cancer is very prone to metastasis, the prognosis of patients is poor, and the 5-year survival rate is low
Chemotherapy is one of the main methods for the treatment of lung cancer. Among them, cisplatin (DDP) is the best chemotherapy drug for the treatment of lung cancer and belongs to the first-line chemotherapy drug in the treatment of lung cancer. The dose and frequency of clinical application, which greatly reduces its anticancer effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition and application thereof
  • Cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition and application thereof
  • Cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] This embodiment provides a combined anti-lung cancer method of cisplatin and Tri-1. This embodiment detects that when the two are used in combination, Tri-1 reverses the drug resistance of tumor cells to cisplatin. The specific steps are as follows:

[0028] (1) The effect of cisplatin monotherapy on the proliferation of normal lung cancer cell A549 and cisplatin-resistant lung cancer cell A549 / DDP was detected by MTT: both cells were treated with 10% fetal bovine serum, 100 kU / L penicillin, 100 mg / L streptomycin in DMEM high-glucose medium, 37°C, 5% CO by volume 2 cultivated under conditions. The cells were trypsinized and counted with a hemocytometer. Inoculate in a 96-well cell culture plate at a volume of 100 μL per well (cell inoculation volume is 8000-10000 per well, selected according to cell size and growth rate), and the volume ratio is 5% CO 2 After 24 hours of cultivation in a 37°C incubator, cisplatin with different concentration gradients was added, and t...

Embodiment 2

[0031] This embodiment provides a method for combining cisplatin and Tri-1 against lung cancer. When the two are used in combination, Tri-1 enhances the inhibitory effect of cisplatin on cell migration. The specific steps are as follows:

[0032] Scratch test to detect the effect on cell migration: First, use a Marker pen on the back of the 6-well plate, compare it with a ruler, and draw horizontal lines evenly, approximately every 1.0 cm, across the wells, 3 lines per well. After the cells to be used were digested with trypsin, they were counted with a hemocytometer. The cell density is 5×10 5 Cells / well were inoculated in a 6-well cell culture plate. 24 hours after inoculating the cells, use a 200uL pipette tip to compare the ruler, and scratch perpendicular to the horizontal line on the back as much as possible. Then wash the cells twice with PBS buffer, remove the scratched cells, take pictures under the microscope, record the scratches at 0 hours after adding the drug, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition and application thereof. The pharmaceutical composition disclosed by the invention comprises cis-platinum and Tri-1. The cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition is prepared by the following method that the cis-platinum and the Tri-1 are weighed and are respectively dissolved in normal saline and dimethyl sulfoxide, a storage solution in which the cis-platinum concentration is 50-200 mmol / L and the Tri-1 concentration is 50-100 mmol / L is prepared, and the storage solution is stored at-20 DEG C to obtain the cis-platinum and Tri-1 combined anti-lung-cancer pharmaceutical composition. When the pharmaceutical composition is used for treating lung cancer, the drug resistance of tumor cells to the cis-platinum can be reduced, the inhibiting effect of the cis-platinum on tumor cell migration is enhanced, the dosage is reduced, the curative effect of the medicine is improved, and side effects are reduced.

Description

technical field [0001] The invention relates to pharmaceutical composition technology, in particular to a combined anti-lung cancer pharmaceutical composition of cisplatin and Tri-1 and its application. Background technique [0002] Lung cancer is a malignant tumor most related to the human respiratory system. According to the 2020 global cancer statistics, lung cancer is still the leading cause of cancer death, accounting for 18.0% of the total cancer deaths. One of the reasons for the extremely high mortality rate of lung cancer is that when most patients are diagnosed with lung cancer, they are already in the advanced stage of cancer, and have missed the best treatment period. Moreover, lung cancer is very prone to metastasis, and the prognosis of patients is poor, and the 5-year survival rate is low. Chemotherapy is one of the main methods for the treatment of lung cancer. Among them, cisplatin (DDP) is the best chemotherapy drug for the treatment of lung cancer and belo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/243A61K31/44A61P35/00
CPCA61K33/243A61K31/44A61P35/00A61K2300/00
Inventor 郭建丽许建强徐卫平贺高红包永明闫志刚代新英
Owner DALIAN UNIV OF TECH PANJIN INST OF IND TECH